125 related articles for article (PubMed ID: 34962348)
21. Effects of Icodextrin and Glucose Bicarbonate/Lactate-Buffered Peritoneal Dialysis Fluids on Effluent Cell Population and Biocompatibility Markers IL-6 and CA125 in Incident Peritoneal Dialysis Patients.
Opatrná S; Pöpperlová A; Lysák D; Fuchsová R; Trefil L; Racek J; Topolčan O
Ther Apher Dial; 2016 Apr; 20(2):149-57. PubMed ID: 26929256
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic and prognostic role of peritoneal CA 125 in peritoneal dialysis patients presenting with acute peritonitis.
Panorchan K; Davenport A
BMC Nephrol; 2014 Sep; 15():149. PubMed ID: 25217152
[TBL] [Abstract][Full Text] [Related]
23. Changes in Peritoneal Transport and Peritoneal Damage in Japanese Patients Undergoing Peritoneal Dialysis Using Neutral-pH Dialysate: A Retrospective Cohort Study at Two Centers.
Oishi D; Sakurada T; Koitabashi K; Kojima S; Kaneshiro N; Shibagaki Y
Adv Perit Dial; 2018 Nov; 34(2018):5-9. PubMed ID: 30480529
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters.
Rodrigues AS; Martins M; Korevaar JC; Silva S; Oliveira JC; Cabrita A; Castro e Melo J; Krediet RT
Am J Nephrol; 2007; 27(1):84-91. PubMed ID: 17284895
[TBL] [Abstract][Full Text] [Related]
25. Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis.
Chung SH; Heimbürger O; Stenvinkel P; Bergström J; Lindholm B
Nephrol Dial Transplant; 2001 Nov; 16(11):2240-5. PubMed ID: 11682675
[TBL] [Abstract][Full Text] [Related]
26. Preservation of peritoneal catheter for prevention of encapsulating peritoneal sclerosis.
Moriishi M; Kawanishi H; Kawai T; Takahashi S; Hirai T; Shishida M; Watanabe H; Takahashi N
Adv Perit Dial; 2002; 18():149-53. PubMed ID: 12402608
[TBL] [Abstract][Full Text] [Related]
27. Influence of dialysis duration, peritoneal transport parameters, and gender on effluent CA125 concentration in patients on peritoneal dialysis.
Mojahedi MJ; Hami M; Shakeri MT; Hekmat R
Iran J Kidney Dis; 2007 Oct; 1(2):78-81. PubMed ID: 19363281
[TBL] [Abstract][Full Text] [Related]
28. Early Detection of Imminent Encapsulating Peritoneal Sclerosis: Free Water Transport, Selected Effluent Proteins, or Both?
Barreto DL; Sampimon DE; Struijk DG; Krediet RT
Perit Dial Int; 2019; 39(1):83-89. PubMed ID: 30478138
[TBL] [Abstract][Full Text] [Related]
29. Matrix metalloproteinase-2 as a superior biomarker for peritoneal deterioration in peritoneal dialysis.
Hirahara I; Kusano E; Morishita Y; Inoue M; Akimoto T; Saito O; Muto S; Nagata D
World J Nephrol; 2016 Mar; 5(2):204-12. PubMed ID: 26981446
[TBL] [Abstract][Full Text] [Related]
30. Icodextrin and intraperitoneal inflammation.
Moriishi M; Kawanishi H
Perit Dial Int; 2008 Jun; 28 Suppl 3():S96-S100. PubMed ID: 18552274
[TBL] [Abstract][Full Text] [Related]
31. Peritoneal solute transport rate as an independent risk factor for total and cardiovascular mortality in a population of peritoneal dialysis patients.
Janda K; Krzanowski M; Dumnicka P; Kuśnierz-Cabala B; Miarka P; Sułowicz W
Adv Perit Dial; 2014; 30():15-20. PubMed ID: 25338416
[TBL] [Abstract][Full Text] [Related]
32. The cellular contribution to effluent potassium and its relation to free water transport during peritoneal dialysis.
Coester AM; Struijk DG; Smit W; de Waart DR; Krediet RT
Nephrol Dial Transplant; 2007 Dec; 22(12):3593-600. PubMed ID: 17664179
[TBL] [Abstract][Full Text] [Related]
33. Presence of galectin-3 in peritoneal dialysate. Does it have a role in the peritoneal membrane inflammatory process?
Einbinder Y; Siboni A; Zaidenstein S; Cohen-Hagai K; Benchetrit S; Zitman-Gal T
Nephrology (Carlton); 2022 Jan; 27(1):104-108. PubMed ID: 34611952
[TBL] [Abstract][Full Text] [Related]
34. A study of the clinical and biochemical profile of peritoneal dialysis fluid low in glucose degradation products.
Lai KN; Lam MF; Leung JC; Chan LY; Lam CW; Chan IH; Chan HW; Li CS; Wong SS; Ho YW; Cheuk A; Tong MK; Tang SC
Perit Dial Int; 2012; 32(3):280-91. PubMed ID: 22045098
[TBL] [Abstract][Full Text] [Related]
35. Relationship of peritoneal transport rate and dialysis adequacy with inflammation in peritoneal dialysis patients.
Fein PA; Fazil I; Rafiq MA; Schloth T; Matza B; Chattopadhyay J; Avram MM
Adv Perit Dial; 2006; 22():2-6. PubMed ID: 16983929
[TBL] [Abstract][Full Text] [Related]
36. Peritoneal membrane phosphate transport status: a cornerstone in phosphate handling in peritoneal dialysis.
Bernardo AP; Contesse SA; Bajo MA; Rodrigues A; Del Peso G; Ossorio M; Cabrita A; Selgas R
Clin J Am Soc Nephrol; 2011 Mar; 6(3):591-7. PubMed ID: 21115631
[TBL] [Abstract][Full Text] [Related]
37. The peritoneal sieving of sodium: a simple and powerful test to rule out the onset of encapsulating peritoneal sclerosis in patients undergoing peritoneal dialysis.
La Milia V; Longhi S; Sironi E; Pontoriero G
J Nephrol; 2018 Feb; 31(1):137-145. PubMed ID: 28012100
[TBL] [Abstract][Full Text] [Related]
38. Vascular endothelial growth factor in peritoneal dialysis patients.
Jovanović N; Božinovski SŽ; Krstić S; Obrenović R; Trbojević-Stanković J; Stojimirović B
Clin Lab; 2014; 60(10):1695-701. PubMed ID: 25651716
[TBL] [Abstract][Full Text] [Related]
39. Differences in peritoneal solute transport rates in peritoneal dialysis.
Asano M; Ishii T; Hirayama A; Mizuno M; Suzuki Y; Sakata F; Akiyama SI; Maruyama S; Soga T; Kinashi H; Katsuno T; Ito Y
Clin Exp Nephrol; 2019 Jan; 23(1):122-134. PubMed ID: 29968125
[TBL] [Abstract][Full Text] [Related]
40. Role of aldose reductase in the peritoneal changes of patients undergoing peritoneal dialysis.
Hasuike Y; Moriguchi R; Hata R; Miyagawa K; Kuragano T; Aizawa M; Yamamoto S; Yanase K; Izumi M; Tanimoto T; Nakanishi T
Am J Nephrol; 2007; 27(6):622-9. PubMed ID: 17851230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
